We examined the correlations between plasma and CSF GFAP levels, CSF sTREM2, CSF YKL40, and CSF S100β with CSF biomarkers of the main pathogenic events described in AD (Figure 2; Table S1). This evidence concerns the gene GFAP and Alzheimer disease.